While agreement of k=0.7 between Euroline and IP has previously been established for anti-TIF-1γ antibody detection in two studies (13, 14), those studies referred to patients with myositis, while in our study the main disagreement reflected other diseases. The gene discussed is TRIM33; the disease is myositis disease.